Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
David S. Arnold, MD
JCP
Letter to the Editor
Adjuvant Therapeutic Effects of Galantamine on Apathy in a Schizophrenia Patient
December 15, 2004
David S. Arnold
,
Richard B. Rosse
,
Dwight Dickinson
, et al
